CCN3 promotes prostate cancer bone metastasis by modulating the tumor–bone microenvironment through RANKL-dependent pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCN3 promotes prostate cancer bone metastasis by modulating the tumor–bone microenvironment through RANKL-dependent pathway
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 7, Pages 1669-1679
Publisher
Oxford University Press (OUP)
Online
2013-03-28
DOI
10.1093/carcin/bgt103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells
- (2012) P.-C. Chen et al. CARCINOGENESIS
- CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis
- (2012) Véronique Ouellet et al. Journal of Cell Communication and Signaling
- Impact of CCN3 (NOV) glycosylation on migration/invasion properties and cell growth of the choriocarcinoma cell line Jeg3
- (2011) W. Yang et al. HUMAN REPRODUCTION
- CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway
- (2011) Huey-En Tzeng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption
- (2011) Young Sun Hwang et al. ORAL ONCOLOGY
- Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model
- (2011) Tzong-Tyng Hung et al. PLoS One
- Nephroblastoma overexpressed gene (NOV) enhances cell motility and COX-2 upregulation of human osteosarcoma involves αvβ5 integrin, ILK and AP-1-dependent pathways
- (2010) Chun-Yin Huang et al. BIOCHEMICAL PHARMACOLOGY
- The bone remodeling environment is a factor in breast cancer bone metastasis
- (2010) Li Laine Ooi et al. BONE
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials
- (2009) Márcio Machado et al. CLINICAL THERAPEUTICS
- Prognostic relevance of CCN3 in Ewing sarcoma
- (2009) Bernard Perbal et al. HUMAN PATHOLOGY
- Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1
- (2008) Yuko Katsuki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CCN3 – A key regulator of the hematopoietic compartment
- (2008) L. McCallum et al. BLOOD REVIEWS
- Prognostic Value of CCN3 in Osteosarcoma
- (2008) B. Perbal et al. CLINICAL CANCER RESEARCH
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Functions and mechanisms of action of CCN matricellular proteins
- (2008) Chih-Chiun Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Screening for Prostate Cancer: An Update
- (2007) Richard J. Bryant et al. EUROPEAN UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started